Evaluation of sequential method of contraception with megestrol acetate and ethinyl oestradiol.
Kanitkar
S D
SD
Ranade
V D
VD
D002490:Central Nervous System; D003085:Colic; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D004194:Disease; D004997:Ethinyl Estradiol; D005069:Evaluation Studies as Topic; D005193:Family Planning Services; D006261:Headache; D006470:Hemorrhage; D019290:Megestrol Acetate; D008796:Metrorrhagia; D009325:Nausea; D012106:Research; D012816:Signs and Symptoms; D014839:Vomiting
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D004997:Ethinyl Estradiol; D019290:Megestrol Acetate
Abdominal Cramps; Bleeding; Central Nervous System Effects; Clinical Research; Contraception; Contraceptive Agents, Estrogen--side effects; Contraceptive Agents, Female--side effects; Contraceptive Agents, Progestin--side effects; Contraceptive Agents--side effects; Contraceptive Effectiveness; Contraceptive Methods; Contraceptive Methods--side effects; Diseases; Ethinyl Estradiol--side effects; Evaluation; Family Planning; Headache; Megestrol Acetate--side effects; Metrorrhagia; Nausea; Oral Contraceptives, Combined; Oral Contraceptives, Phasic; Oral Contraceptives--side effects; Research Methodology; Signs And Symptoms; Use-effectiveness; Vomiting